Skip to content
Cerevel Therapeutics and Abbvie

Cerevel Therapeutics and Abbvie

Tavapadon (PF-06649751) is a dopamine receptor agonist targeting motor impairment in Parkinson’s disease. This small molecule aims to improve motor control by stimulating dopamine receptors in the brain.

Cart 0

Your cart is currently empty.

Start Shopping